"Das Florence-Nightingale-Krankenhaus der Kaiserswerther Diakonie im Düsseldorfer Norden ist eine der modernsten Kliniken Düsseldorfs. Hier finden Erwachsene und Kinder eine verlässliche und sichere Adresse, wenn es um ihre Gesundheit geht. Zwölf Fachkliniken, mehrere zertifizierte Zentren sowie vielfältige Pflege-, Betreuungs- und Therapieangebote stehen für die Behandlung der Patienten zur Verfügung. Spezialgebiete im Florence-Nightingale-Krankenhaus sind u.a. die Familien- und Tumormedizin. Nach umfassender Modernisierung und Neubauten sorgt das Funktionsgebäude mit bester medizintechnischer Ausstattung und kurzen Wegen für höchste Patientensicherheit."

During the past decade, Florence Nightingale Krankenhaus conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 4 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florence Nightingale Krankenhaus" #1 sponsor was "Hoffmann-La Roche" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "ResMed" with 3 trials sponsored, "Abivax S.A." with 2 trials sponsored and "Arena Pharmaceuticals" with 2 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florence Nightingale Krankenhaus" #1 collaborator was "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom Germany" with 1 trials as a collaborator, "Belgium Gynecologic Oncology Group" with 1 trials as a collaborator, "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Florence Nightingale Krankenhaus" are "Ulcerative Colitis" (4 trials), "Crohn's Disease" (3 trials), "Heart Failure" (2 trials), "Lymphoma" (2 trials) and "Adverse Effect of Handovers of Anesthesia Care" (1 trials). Many other conditions were trialed in "Florence Nightingale Krankenhaus" in a lesser frequency.

Most popular intervention types in "Florence Nightingale Krankenhaus" are "Drug" (13 trials), "Biological" (4 trials), "Procedure" (3 trials), "Device" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Guselkumab" (3 trials), "Etrasimod" (2 trials), "Golimumab" (2 trials) and "JNJ-78934804" (2 trials). Other intervention names were less common.

The vast majority of trials in "Florence Nightingale Krankenhaus" are 17 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Florence Nightingale Krankenhaus". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Florence Nightingale Krankenhaus, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Florence Nightingale Krankenhaus, 1 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".